Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

557 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impact of epoetin beta on quality of life in patients with malignant disease.
Boogaerts M, Coiffier B, Kainz C; Epoetin beta QOL Working Group. Boogaerts M, et al. Br J Cancer. 2003 Apr 7;88(7):988-95. doi: 10.1038/sj.bjc.6600801. Br J Cancer. 2003. PMID: 12671693 Free PMC article. Clinical Trial.
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.
Mounier N, Morel P, Haioun C, Coiffier B, Tilly H, Chatelain C, Lederlin P, Thyss A, Herbrecht R, Gisselbrecht C, Lepage E. Mounier N, et al. Cancer. 1998 May 15;82(10):1952-62. Cancer. 1998. PMID: 9587130 Clinical Trial.
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
Warzocha K, Bienvenu J, Ribeiro P, Moullet I, Dumontet C, Neidhardt-Berard EM, Coiffier B, Salles G. Warzocha K, et al. Br J Cancer. 1998 Jun;77(12):2357-62. doi: 10.1038/bjc.1998.391. Br J Cancer. 1998. PMID: 9649158 Free PMC article.
Elevated plasma levels of TNF, p55 and p75 were also associated with several parameters reflecting an immune activation, including the presence of B symptoms, elevated serum levels of gammaglobulins, alkaline phosphatase and fibrinogen, as well as peripheral monocytosis, a …
Elevated plasma levels of TNF, p55 and p75 were also associated with several parameters reflecting an immune activation, including the prese …
Long term outcome of patients with hairy cell leukemia treated with pentostatin.
Ribeiro P, Bouaffia F, Peaud PY, Blanc M, Salles B, Salles G, Coiffier B. Ribeiro P, et al. Cancer. 1999 Jan 1;85(1):65-71. doi: 10.1002/(sici)1097-0142(19990101)85:1<65::aid-cncr9>3.0.co;2-b. Cancer. 1999. PMID: 9921975 Clinical Trial.
Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey.
Coiffier B, Guastalla JP, Pujade-Lauraine E, Bastit P; Anemia Study Group. Coiffier B, et al. Eur J Cancer. 2001 Sep;37(13):1617-23. doi: 10.1016/s0959-8049(01)00169-1. Eur J Cancer. 2001. PMID: 11527686 Clinical Trial.
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
Cazzola M, Beguin Y, Kloczko J, Spicka I, Coiffier B. Cazzola M, et al. Br J Haematol. 2003 Aug;122(3):386-93. doi: 10.1046/j.1365-2141.2003.04439.x. Br J Haematol. 2003. PMID: 12877665 Clinical Trial.
Epoetin once weekly in anaemic patients with cancer.
Coiffier B. Coiffier B. Br J Haematol. 2004 Apr;125(1):100-1; author reply 101-2. doi: 10.1111/j.1365-2141.2004.04887.x. Br J Haematol. 2004. PMID: 15015984 No abstract available.
Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: A meta-analysis.
Aapro M, Coiffier B, Dunst J, Osterborg A, Burger HU. Aapro M, et al. Br J Cancer. 2006 Dec 4;95(11):1467-73. doi: 10.1038/sj.bjc.6603481. Epub 2006 Nov 21. Br J Cancer. 2006. PMID: 17117175 Free PMC article.
557 results
Jump to page
Feedback